UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ Preliminary Proxy Statement
☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐ Definitive Proxy Statement
☒ Definitive Additional Materials
☐ Soliciting Material under §240.14a-12
Cue Biopharma, Inc.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
☒ No fee required
☐ Fee paid previously with preliminary materials
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
styleINA
of Proxy Materials for the Stockholders
Meeting To Be Held On June 5, 2024 For
Stockholders of Record on April 12, 2024
To order paper materials, use one of the
following methods.
onement thereof. styleINA
Scan QR for
digital voting
P.O. BOX 8016, CARY, NC 27512-9903
Your vote
matters!
Cue Biopharma, Inc.
Annual Meeting of Stockholders
Wednesday, June 5, 2024 9:00 AM, Eastern Time
Annual Meeting to be held virtually via the internet - please visit www.proxydocs.com/CUE for
more details.
You must pre-register to attend the meeting online and/or participate at
www.proxydocs.com/CUE.
For a convenient way to view proxy materials, VOTE, and obtain
directions to attend the meeting, go to www.proxydocs.com/CUE
To vote your proxy while visiting this site, you will need the 12 digit
control number in the box below.
This communication presents only an overview of the more complete proxy materials that are
available to you on the Internet. This is not a ballot. You cannot use this notice to vote your
shares. We encourage you to access and review all of the important information contained in
the proxy materials before voting.
Under United States Securities and Exchange Commission rules, proxy materials do not have
to be delivered in paper, unless requested. Proxy materials can be distributed by making them
available on the internet.
If you want to receive a paper or e-mail copy of the proxy materials, you must request one.
There is no charge to you for requesting a copy. In order to receive paper materials in time for
this year's meeting, you must make this request on or before May 24, 2024.
Proxy Materials Available to View or Receive: Proxy
Statement, Proxy Card & Annual Report
Important Notice Regarding the Availability
of Proxy Materials for the Stockholders
Meeting To Be Held On June 5, 2024 For
Stockholders of Record on April 12, 2024
To order paper materials, use one of the
following methods.
Internet:
www.investorelections.com/CUE
Call:
1-866-648-8133
Email:
paper@investorelections.com
* If requesting material by e-mail, please send a blank e-mail with the
12 digit control number (located below) in the subject line. No other
requests, instructions OR other inquiries should be included with your
e-mail requesting material.
Your control number
Have the 12 digit control number located in the
box above available when you access the
website and follow the instructions.
SEE REVERSE FOR FULL AGENDA
Copyright © 2024 BetaNXT, Inc. or its affiliates. All Rights Reserved
Cue Biopharma, Inc. Annual Meeting of Stockholders
THE BOARD OF DIRECTORS RECOMMENDS A VOTE:
FOR EACH NOMINEE IN PROPOSAL 1, FOR PROPOSAL 2, AND FOR PROPOSAL 3
PROPOSAL
1. Election of six directors to our board of directors, each to serve until the 2025 annual meeting of stockholders:
1.01 Daniel R. Passeri
1.02 Frank Morich
1.03 Frederick Driscoll
1.04 Pamela Garzone
1.05 Peter A. Kiener
1.06 Patrick Verheyen
2. The ratification of the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31,
2024.
3. The approval, on a non-binding advisory basis, of the compensation of our named executive officers.
NOTE: The proxies are authorized to vote, in their discretion, upon such other business that may properly come before the Annual Meeting or
any adjournment or postponement thereof.